Search

Ruth Palmer Lab

Ruth Palmer Lab

News
People
Events
Publications
Contact
Funding

Jakob Stenman

Latest

Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib

© 2026 DL . This work is licensed under CC BY NC ND 4.0

Published with Hugo Blox Builder — the free, open source website builder that empowers creators.

Cite